Neogen Gross Profit 2011-2025 | NEOG
Neogen gross profit from 2011 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
|
Neogen Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $421 |
| 2024 | $464 |
| 2023 | $406 |
| 2022 | $243 |
| 2021 | $215 |
| 2020 | $196 |
| 2019 | $192 |
| 2018 | $186 |
| 2017 | $169 |
| 2016 | $153 |
| 2015 | $140 |
| 2014 | $123 |
| 2013 | $109 |
| 2012 | $92 |
| 2011 | $88 |
|
Neogen Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-08-31 | $95 |
| 2025-05-31 | $93 |
| 2025-02-28 | $110 |
| 2024-11-30 | $113 |
| 2024-08-31 | $105 |
| 2024-05-31 | $113 |
| 2024-02-29 | $117 |
| 2023-11-30 | $117 |
| 2023-08-31 | $117 |
| 2023-05-31 | $123 |
| 2023-02-28 | $108 |
| 2022-11-30 | $113 |
| 2022-08-31 | $62 |
| 2022-05-31 | $65 |
| 2022-02-28 | $57 |
| 2021-11-30 | $61 |
| 2021-08-31 | $60 |
| 2021-05-31 | $58 |
| 2021-02-28 | $54 |
| 2020-11-30 | $53 |
| 2020-08-31 | $50 |
| 2020-05-31 | $52 |
| 2020-02-29 | $45 |
| 2019-11-30 | $51 |
| 2019-08-31 | $48 |
| 2019-05-31 | $51 |
| 2019-02-28 | $45 |
| 2018-11-30 | $50 |
| 2018-08-31 | $47 |
| 2018-05-31 | $48 |
| 2018-02-28 | $45 |
| 2017-11-30 | $48 |
| 2017-08-31 | $45 |
| 2017-05-31 | $44 |
| 2017-02-28 | $41 |
| 2016-11-30 | $44 |
| 2016-08-31 | $40 |
| 2016-05-31 | $42 |
| 2016-02-29 | $35 |
| 2015-11-30 | $38 |
| 2015-08-31 | $38 |
| 2015-05-31 | $38 |
| 2015-02-28 | $34 |
| 2014-11-30 | $34 |
| 2014-08-31 | $34 |
| 2014-05-31 | $32 |
| 2014-02-28 | $31 |
| 2013-11-30 | $29 |
| 2013-08-31 | $30 |
| 2013-05-31 | $28 |
| 2013-02-28 | $27 |
| 2012-11-30 | $27 |
| 2012-08-31 | $26 |
| 2012-05-31 | $24 |
| 2012-02-29 | $23 |
| 2011-11-30 | $23 |
| 2011-08-31 | $23 |
| 2011-05-31 | $22 |
| 2011-02-28 | $21 |
| 2010-11-30 | $22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.384B | $0.895B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.767B | 25.90 |
| EssilorLuxottica (ESLOY) | France | $171.623B | 0.00 |
| Boston Scientific (BSX) | United States | $155.627B | 35.59 |
| Stryker (SYK) | United States | $142.805B | 28.35 |
| Medtronic (MDT) | Ireland | $123.317B | 17.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.676B | 0.00 |
| Agilent Technologies (A) | United States | $41.643B | 26.95 |
| ResMed (RMD) | United States | $36.793B | 25.47 |
| GE HealthCare Technologies (GEHC) | United States | $33.695B | 16.11 |
| Koninklijke Philips (PHG) | Netherlands | $27.848B | 18.19 |
| Insulet (PODD) | United States | $23.402B | 72.64 |
| Terumo (TRUMY) | Japan | $22.490B | 25.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.949B | 11.19 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.072B | 0.00 |
| Baxter (BAX) | United States | $9.613B | 7.76 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.548B | 30.74 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.522B | 10.73 |
| Haemonetics (HAE) | United States | $3.460B | 15.40 |
| ICU Medical (ICUI) | United States | $3.420B | 21.71 |
| Envista Holdings (NVST) | United States | $3.270B | 18.76 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.885B | 13.16 |
| LeMaitre Vascular (LMAT) | United States | $2.034B | 40.93 |
| Perrigo (PRGO) | Ireland | $1.923B | 4.82 |
| Phibro Animal Health (PAHC) | United States | $1.812B | 18.10 |
| Curaleaf Holdings (CURLF) | Canada | $1.735B | 0.00 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.507B | 9.69 |
| Green Thumb Industries (GTBIF) | United States | $1.379B | 60.46 |
| Kestra Medical Technologies (KMTS) | United States | $1.282B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.269B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 18.29 |
| BioLife Solutions (BLFS) | United States | $1.210B | 359.14 |
| InMode (INMD) | Israel | $0.904B | 10.21 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.794B | 0.00 |
| Surmodics (SRDX) | United States | $0.592B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.499B | 17.17 |
| Evolus (EOLS) | United States | $0.478B | 0.00 |
| CeriBell (CBLL) | United States | $0.463B | 0.00 |
| SNDL (SNDL) | Canada | $0.447B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.427B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.381B | 0.00 |
| Cerus (CERS) | United States | $0.307B | 0.00 |
| Brainsway (BWAY) | Israel | $0.304B | 53.37 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.264B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.264B | 0.00 |
| High Tide (HITI) | Canada | $0.250B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 146.33 |
| Quanterix (QTRX) | United States | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.244B | 19.42 |
| Owens & Minor (OMI) | United States | $0.227B | 2.27 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.212B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.191B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 15.85 |
| Sanara MedTech (SMTI) | United States | $0.175B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.173B | 21.33 |
| OraSure Technologies (OSUR) | United States | $0.164B | 0.00 |
| Apyx Medical (APYX) | United States | $0.156B | 0.00 |
| Biote (BTMD) | United States | $0.119B | 5.20 |
| Jushi Holdings (JUSHF) | United States | $0.106B | 0.00 |
| MacroGenics (MGNX) | United States | $0.101B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 13.27 |
| Sharps Technology (STSS) | United States | $0.091B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 23.27 |
| Nephros (NEPH) | United States | $0.047B | 34.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Bonk (BNKK) | United States | $0.030B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.35 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Zynex (ZYXI) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.010B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |